Board approves Interim Dividend

5th November, 2026 The Manager – Listing The Manager – Listing National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Plot No. C/1, Block – G Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Scrip Code: EMAMILTD Scrip Code: 531162 Sub: Outcome of Board Meeting held on 5th November, 2026 Dear Sir/ Madam, In furtherance to our intimation dated 24th October, 2026, and pursuant to Regulation 30 and other applicable regulations (if any) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), this is to inform you that the Board of Directors of the Company, at its meeting held today, i.e, 5th November, 2026, has inter-alia: 1. considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half-year ended 30th September, 2026. In this regard, pursuant to Regulation 33 of the Listing Regulations, we are enclosing herewith the Unaudited Financial Results (Standalone & Consolidated) of the Company, for the quarter and half- year ended 30th September, 2026, along with the Limited Review Report, issued by the Statutory Auditors of the Company – marked as Annexure - A; The full format of the aforesaid results is annexed herewith for making the same available on the website of the Stock Exchanges. The results are also available on the Company’s website at www.emamiltd.in. 2. declared and approved the payment of 1st Interim Dividend of Rs. 5/- per equity share having face value of Re. 1/- each fully paid up i.e. 500% on 42,92,00,000 equity shares of the Company for the financial year 2026-27. The interim dividend will be paid on or before 4th December, 2026. Record date for ascertaining the name of the members / beneficial owners who will be entitled to receive the Interim Dividend is Friday, 13th November, 2026. 3. considered and approved the appointment of Shri Debendra Banthiya, qualified Company Secretary (ICSI Membership No – F7790), as the Company Secretary & Compliance Officer of the Company with effect from 5th November, 2026. The details required as per Regulation 30 of the Listing Regulations, and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, are enclosed and marked as Annexure – B; Further, Shri Debendra Banthiya has also been appointed as the Nodal Officer of the Company, in compliance with Rule 7 (2A) of Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. The Board meeting commenced at 12:00 Noon and concluded at 1:35 P.M. The aforesaid information will also be available on the Company’s website at www.emamiltd.in. This is for your information and record. Thanking you, Yours faithfully, For Emami Limited N.H. Bhansali CEO- Finance, Strategy & Business Development and CFO (Encl: As above) Annexure - A 22, Camac Street 3rd Floor, Block ‘B’ Kolkata – 700 016, India Tel: +91 33 6134 4000 Chartered Accountants Independent Auditor’s Review Report on the Quarterly and Year to Date Unaudited Consolidated Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Emami Limited 1. We have reviewed the accompanying Statement of Unaudited Consolidated Financial Results of Emami Limited (the “Holding Company”) and its subsidiaries (the Holding Company and its subsidiaries together referred to as “the Group”) and its associates for the quarter ended September 30, 2026 and year to date from April 01, 2026 to September 30, 2026 (the “Statement”) attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). 2. The Holding Company’s Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) “Interim Financial Reporting” prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Holding Company’s Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the Master Circular issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable except with respect to one (1) subsidiary (including their two (2) subsidiaries), for S.R. Batliboi & Co. LLP, a Limited Liability Partnership with LLP Identity No. AAB-4294 Chartered Accountants which auditor have not reviewed the results for the quarter ended September 30, 2026 (also refer “Basis of Qualified conclusion paragraph”). 4. The Statement includes the results of the following entities: Entity Relationship Emami Limited Holding Company Emami Bangladesh Limited Subsidiary of Emami Limited Emami International FZE Subsidiary of Emami Limited Emami Lanka (Pvt) Limited Subsidiary of Emami Limited Brillare Science Limited (Formerly Subsidiary of Emami Limited Brillare Science Private Limited) Helios Lifestyle Limited (Formerly Helios Subsidiary of Emami Limited Lifestyle Private Limited) IncNut Digital Private Limited Subsidiary of Emami Limited (w.e.f June 01, 2026) IncNut Lifestyle Retail Private Limited Subsidiary of IncNut Digital Private Limited Axiom Ayurveda Private Limited Subsidiary of Emami Limited (w.e.f April 01, 2026) Axiom Foods and Beverages Private Subsidiary of Axiom Ayurveda Private Limited Limited Axiom Packwell Private Limited Subsidiary of Axiom Ayurveda Private Limited Emami International Personal Care LLC Subsidiary of Emami International FZE Emami RUS (LLC) Subsidiary of Emami International FZE Crème 21 GMBH (Formerly Fentus 113. Subsidiary of Emami International FZE GMBH) Overseas International FZE (Formerly Subsidiary of Emami International FZE known as Emami Overseas FZE) Emami Neo-Herbals International Ltd. Subsidiary of Emami International FZE PharmaDerm Company SAE Subsidiary of Emami Overseas FZE Tru Native F&B Private Limited Associate of Emami Limited Cannis Lupus Services India Private Associate of Emami Limited Limited Chartered Accountants Basis for Qualified Conclusion 5. As disclosed in the note 3(a) to the Statement, the accompanying Statement of unaudited consolidated financial results include unaudited interim financial results and other unaudited financial information in respect of Consolidated financial results of One (1) subsidiary (including its two (2) subsidiaries), whose interim financial information/ financial results reflect total revenues of Rs. 8,357 lacs, total net profit after tax of Rs. 941 lacs and total comprehensive income of Rs. 946 lacs for the quart [Showing first 8,000 characters — download PDF for full document]